Liver Disease Market was US$ 16.21 Billion in 2021. Industry Trends, Growth, Insight, Outlook, Impact of Inflation, Company Analysis, Global Forecast 2023-2027
Liver Disease Market will reach US$ 26.30 Billion in 2027. In the human body, the liver is a vital organ that plays significant functions like storing vitamins and nutrients, maintaining an adequate balance of chemicals in the body, and removing harmful substances from the blood. Non-alcoholic Fatty Liver Disease, Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases.
As per the study “Burden of Liver Diseases in the World,” issued in 2019, globally, liver disorders account for about 2 million deaths per year, out of which 1 million are due to viral hepatocellular carcinoma, and hepatitis, as well as 1 million are owing to complications of cirrhosis. Cirrhosis is the 11th most common cause of death worldwide, and liver cancer is the 16th leading cause of death.
Liver Disease Market Size is likely to expand at a CAGR of 8.40 % during 2021 - 2027:
The liver disease treatment market will show rapid growth due to the rising government initiatives of providing vaccines, growing awareness about the liver diseases, and increased consumption of alcohol and improper diet. Furthermore, with the prevalence of liver disorders, governments and other not-for-profit organizations play a vital role in increasing awareness about liver diseases. Henceforth all these organizations support research and development for the prevention, promoting the understanding of liver-related diseases and treatment, and cure of liver diseases.
Liver Disease Market was US$ 16.21 Billion in 2021:
Regarding treatment type, the antiviral drugs segment is the largest market in 2021. This trend is likely to continue to grow during the forecast period, owing to the increased prevalence of viral liver diseases.
Based on Region, North America is the most significant market for Liver Disease Treatment:
In terms of region, North America leads the market owing to research and academic institutes conducting clinical trial studies in the region. Changing lifestyles, such as the growing consumption of alcohol and unhealthy diets, have also raised the incidences of liver disease. Additionally, growing patient awareness levels and introducing new products targeting unmet medical demands are projected to drive regional market growth over the coming year.
Impact of COVID-19 on Liver Disease Market:
The increasing number of COVID-19 cases has found liver disorder involvement. In COVID-19, the cause of liver injury can be recognized by multiple factors, including virus-induced hypoxia, systemic inflammation, hepatic congestion, and drug-induced liver disease.
In addition, COVID-19 has been associated with liver-related mortality and hepatic decompensation among patients with cirrhosis. Further, COVID-19’s effect on healthcare resources has adversely affected the outcomes of patients with chronic liver disease and care delivery. Consequently, there has been a reduction in the diagnosis, treatment, and follow-up of patients with liver disease, negatively affecting the healthcare industry.
Competitive Landscape:
Various companies like Abbott Laboratories, Eli Lilly, Sanofi, Johnson & Johnson, Bristol Myers Squibb Co., Merck & Co. Inc., and Bayer AG are found advanced treatment drugs for liver diseases and investing in their R&D to develop innovative.
The publisher's latest report “Liver Disease Market, Forecast By Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteriods, Targeted Therapy, Chemotherapy), Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease, Cancer, Genetic Disorders and Others),End-User (Hospitals, Ambulatory Surgery Centers, Other),Region ( North America, Europe, Asia Pacific, LAMEA),Companies (Abbott Laboratories, Eli Lilly, Sanofi, Johnson & Johnson, Bristol Myers Squibb Co., Merck & Co. Inc., and Bayer AG)” provides a detailed analysis of Global Liver Disease Industry.
Treatment Type - Global Liver Disease Market has been covered from 7 viewpoints:
1. Antiviral Drugs
2. Immunosuppressants
3. Vaccines
4. Immunoglobulins
5. Corticosteriods
6. Targeted Therapy
7. Chemotherapy
Disease Type - Global Liver Disease Market has been covered from 6 viewpoints:
1. Hepatitis
2. Autoimmune Diseases
3. Non-alcoholic Fatty Liver Disease
4. Cancer
5. Genetic Disorders
6. Others
End Use - Global Liver Disease Market has been covered from 3 viewpoints:
1. Hospitals
2. Ambulatory Surgery Centers
3. Other
Region - Global Liver Disease Market has been covered from 4 viewpoints:
1. North America
2. Europe
3. Asia Pacific
4. LAMEA
Company Insights:
- Overview
- Initiatives/Recent Developments
- Financial Insight
Companies Covered:
1. Abbott Laboratories
2. Eli Lilly
3. Sanofi
4. Johnson & Johnson
5. Bristol Myers Squibb Co.
6. Merck & Co. Inc.
7. Bayer AG
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Eli Lilly
- Sanofi
- Johnson & Johnson
- Bristol Myers Squibb Co.
- Merck & Co. Inc.
- Bayer AG
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | October 2022 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 17.57 Billion |
| Forecasted Market Value ( USD | $ 26.3 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
